IDXXIdexx Laboratories
Price
-21%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, no red flags, price roughly fair, growing in the filings, the market undecided.
IDEXX was incorporated in Delaware in 1983. We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. We also manufacture and sell human medical point-of-care diagnostic products. Our primary products and services are: Our Purpose is to be a great company that creates exceptional long-term value for our customers, employees, and stockholders by enhancing the health and well-being of pets, people, and livestock.
In the company’s own words · 10-K filed Feb 20, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Idexx Laboratories (IDXX) reported revenue of $1.22B in Q2 2026 (quarter ended Jun 30, 2026), up 9.7% from the same quarter a year earlier. That came with a gross margin of 64% and net income of $338M (28% of revenue). For the full year FY2025, revenue was $4.30B (+10% year on year) and net income $1.06B. Its largest product in Q2 2026 was Vet Lab Consumables at $430M, 35% of the disclosed total, just ahead of Reference Laboratory Diagnostic And Consulting Services at 33%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 4, 2026Laboratories Announces Second Quarter Results.Earnings release · press release
- May 15, 2026Certificate of Incorporation At the 2026 annual meeting of shareholders of IDEXX Laboratories, Inc. (the “Corporation”) held on May 12, 2026 (the “Annual Meeting”), upon the recommendation of the Corporation’s Board of Directors (the “Board”), the Corporation’s shareholders approved amendments to the Corporation’s …Charter/bylaw amendment or fiscal-year change · Form 8-K
- May 5, 2026IDEXX Laboratories Announces First.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q2 2026 · $1.21BThe company’s own SEC segment disclosure.
- Vet Lab Consumables$430.3M35%
- Reference Laboratory Diagnostic And Consulting Services$406.7M33%
- Rapid Assay Products$101.6M8%
- Veterinary Software Services And Diagnostic Imaging Systems$96.3M8%
- Recurring$76.3M6%
- CAG Diagnostic Capital Instruments$47.2M4%
- Other (2)$56.1M5%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Diagnostics & Research
The closest names by size in the same industry